TASC-3B (Trace element ATORG Study COVID-19 in Berlin, Bavaria, and Baden-Württemberg): Characterization of COVID-19 infections using parameters of the immune system and trace element status

TASC-3B (Trace element ATORG Study COVID-19 in Berlin, Bavaria, and Baden-Württemberg): Characterization of COVID-19 infections using parameters of the immune system and trace element status - TASC-3B

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022294

Enrollment

300

Registered

2020-09-14

Start date

2020-06-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 COVID-19

Interventions

Group 1: Patients with evidence of COVID-19 are examined for the dynamics of trace element concentrations and immunologically active cells in serum or whole blood. The results are correlated with the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Reasonable suspicion of COVID-19 infection RKI - Detection of a COVID-19 infection via RT-PCR - patient's consent

Exclusion criteria

Exclusion criteria: - No patient consent - Age under 18 years

Design outcomes

Primary

Measure	Time frame
Severe course of COVID-19 infection; Indicators: interstitial pneumonia, ARDS	—

Secondary

Measure	Time frame
Length of stay in the hospital, duration of treatment in the intensive care unit, ventilation required during the course, duration of ventilation.	—

Countries

Germany

Contacts

Public ContactRaban Heller

Universitätsklinikum Heidelberg

raban.heller@med.uni-heidelberg.de+4962215635353

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026